KAWAS LEEN enters EIGER BIOPHARMACEUTICALS, INC. with 4.37M shares across direct and indirect positions
This filing by KAWAS LEEN establishes the baseline for all future Form 4 insider transaction reports at EIGER BIOPHARMACEUTICALS, INC..
Indirect
Filed: 10/30/2023ACC: 0001140361-23-050235
10% Owner
Since Oct 2023
4.37M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
2
Security positions
4.37M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned1.67M
Common Stock
IndirectShares owned2.70M
Total
4.37M indirect4.37M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.67M | Indirect |
| Common Stock | 2.70M | Indirect |
| Total | 4.37M | 4.37M indirect |
Derivative Holdings0
No derivative holdings reported